• Strategy
  • Innovation
  • Expertise

Agreement to acquire AstraZeneca Insurance Company Limited

23 December, 2016

Randall & Quilter Investment Holdings Ltd (‘R&Q’ or ‘the Group’) is pleased to announce that it has signed an agreement to acquire, subject to a pre-completion capital restructuring and to change of control approval from each of the PRA and FCA, the entire issued share capital of AstraZeneca Insurance Company Limited (‘AZICO’) (‘the Company’) from its owners AstraZeneca UK Limited. AZICO was formed in 1994 as the UK registered captive insurer for AstraZeneca. It ceased active underwriting in 2004. The pre-completion capital restructuring is expected to take place within the same timeframe as the regulatory approval process.

The residual liabilities comprise primarily of UK Employers’ Liability. AZICO had gross claim reserves as at 31st December 2015 amounting to £15.7m. The consideration payable by R&Q, in cash from existing resources and its bank facility with RBS, will depend on the outcome of the capital restructuring but will be between £10.2m to £34.6m. This represents a small discount to the Company’s anticipated post-capital restructuring net assets of £12.9m to £37.9m. In the year to 31st December 2015 no profit or loss was attributable to the assets of the acquisition.

The Company will be managed by R&Q with the intention of undertaking a Part VII Transfer of the remaining insurance business to one of the Group’s consolidation vehicles, subject to the usual regulatory and Court approvals, in due course.

Commenting on today’s announcement, Ken Randall, Chairman and Chief Executive Officer of Randall & Quilter, said:

“We are pleased to have entered into an agreement to acquire AZICO from AstraZeneca UK Limited.

This is the second transaction that we have concluded with AstraZeneca to assist them exiting their captive insurance companies in run-off and further demonstrates the attractions of the Group’s offerings to major corporations.”

Click here for the full Press Release

Agreement to acquire AstraZeneca Insurance Company Limited

Latest News

Allotment of Shares
Allotment of Shares

The Company has issued and allotted a total of 735,895 new ordinary shares of 2p each (“Ordinary Shares”) to an employee as part of their remuneration package. Application has been made to the London Stock Exchange for the admission of …

Notification pursuant to AIM Rule 17
Notification pursuant to AIM Rule 17

Notification pursuant to AIM Rule 17 comprising a notification relating to a relevant change by a significant shareholder in the Company The Company was notified on 4 October that Slater now holds an aggregate of 21,649,842 ordinary shares in the …

R&Q appoints CEO for Legacy Insurance
R&Q appoints CEO for Legacy Insurance

Randall & Quilter Investment Holdings Ltd, (AIM-RQIH) (“R&Q”), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, is pleased to announce the appointment of Andrew (Andy) Pinkes as Global CEO of R&Q’s Legacy Insurance …